In vitro treatment with BMP2 mirrored the effects of CA-MSCs on cancer stem cells while inhibiting BMP signaling, whereas, in vivo, BMP2 partially inhibited MSC-promoted tumor growth. Here, BMP2 is linked to neoplasm.